Literature DB >> 19420758

Preventive effects of salvianolic acid B on transforming growth factor-beta1-induced epithelial-to-mesenchymal transition of human kidney cells.

Gang Yao1, Lizhi Xu, Xiaochun Wu, Lingling Xu, Junwei Yang, Huimei Chen.   

Abstract

Epithelial-mesenchymal transition (EMT) is an important mechanism in kidney fibrosis. While Salvianolic acid-B (Sal B) has been well appreciated to show a protective effect of tissue fibrosis, the objective of this study was to investigate the influence of Sal B on the transdifferentiation of renal tubular epithelial cells. Human kidney proximal tubular cell line (HK-2) was used as the proximal tubular cell model and EMT was induced with 5 ng/ml of human transforming growth factor (TGF)-beta1. The effects of the Sal B on cell morphology were observed by phase contrast microscopy, and the possible mechanisms were studied by immunocytochemistry and real-time reverse transcription-polymerase chain reaction. Our results revealed that Sal B could inhibit TGF-beta1-induced myofibroblast phenotype and restored the epithelial morphology in a dose-dependent manner. It was partially through modulating alpha-smooth muscle actin (SMA) increase and E-cadherin reduction. These observations strongly suggest that Sal B is a potent inhibitor of TGF-beta1-induced EMT and might be a promising agent for treating tubulointerstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420758     DOI: 10.1248/bpb.32.882

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro.

Authors:  Qing-Lan Wang; Yan-Yan Tao; Ji-Li Yuan; Li Shen; Cheng-Hai Liu
Journal:  BMC Cell Biol       Date:  2010-05-05       Impact factor: 4.241

Review 2.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

3.  Inhibition of the tubular epithelial-to-mesenchymal transition in vivo and in vitro by the Uremic Clearance Granule ().

Authors:  Zhao-yu Lu; Shu-wen Liu; Yuan-sheng Xie; Shao-yuan Cui; Xu-sheng Liu; Wen-jia Geng; Xiao Hu; Jia-yao Ji; Xiang-mei Chen
Journal:  Chin J Integr Med       Date:  2013-12-05       Impact factor: 1.978

4.  Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.

Authors:  Yuan Zhao; Yinhan Guo; Xinbin Gu
Journal:  J Oncol       Date:  2010-12-20       Impact factor: 4.375

5.  Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis Model.

Authors:  Yongjian Xiong; Jingyu Wang; Hongwei Chu; Dapeng Chen; Huishu Guo
Journal:  Front Pharmacol       Date:  2016-05-26       Impact factor: 5.810

Review 6.  A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease.

Authors:  Yanhong Ma; Fanghao Cai; Yangyang Li; Jianghua Chen; Fei Han; Weiqiang Lin
Journal:  Bioact Mater       Date:  2020-06-15

7.  Quality Evaluation and Chemical Markers Screening of Salvia miltiorrhiza Bge. (Danshen) Based on HPLC Fingerprints and HPLC-MSn Coupled with Chemometrics.

Authors:  Wenyi Liang; Wenjing Chen; Lingfang Wu; Shi Li; Qi Qi; Yaping Cui; Linjin Liang; Ting Ye; Lanzhen Zhang
Journal:  Molecules       Date:  2017-03-17       Impact factor: 4.411

Review 8.  Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer.

Authors:  Lunkun Ma; Liling Tang; Qian Yi
Journal:  Front Pharmacol       Date:  2019-02-20       Impact factor: 5.810

9.  Salvia miltiorrhiza injection ameliorates renal damage induced by lead exposure in mice.

Authors:  Lei Li; Yuanyuan Zhang; Juanjuan Ma; Weichong Dong; Qiongtao Song; Jianping Zhang; Li Chu
Journal:  ScientificWorldJournal       Date:  2014-02-13

10.  The effects of Salvia przewalskii total phenolic acid extract on immune complex glomerulonephritis.

Authors:  Yang Yang; Zhi-Peng Wang; Shou-Hong Gao; Hong-Qi Ren; Ren-Qian Zhong; Wan-Sheng Chen
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.